Related Links
ARALAST NP AATmosphere Program
Support for Alphas and families from the ARALAST NP AATmosphere program.
Patient Services, Inc.
Are you an Alpha-1 patient experiencing billing and/or insurance issues?
PSI can provide assistance and help.
Baxter supports PSI, a non-profit organization that may offer you help with billing and reimbursement issues.
For more information about the ways PSI can help, visit www.uneedpsi.org or call 1-800-366-7741.
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
